AGILENT TECHNOLOGIES INC (A) Fundamental Analysis & Valuation

NYSE:A • US00846U1016

Current stock price

113.005 USD
-1.87 (-1.62%)
Last:

This A fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. A Profitability Analysis

1.1 Basic Checks

  • A had positive earnings in the past year.
  • In the past year A had a positive cash flow from operations.
  • Each year in the past 5 years A has been profitable.
  • A had a positive operating cash flow in each of the past 5 years.
A Yearly Net Income VS EBIT VS OCF VS FCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of A (10.07%) is better than 91.23% of its industry peers.
  • A has a Return On Equity of 18.67%. This is amongst the best in the industry. A outperforms 92.98% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.56%, A belongs to the top of the industry, outperforming 91.23% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for A is above the industry average of 11.01%.
Industry RankSector Rank
ROA 10.07%
ROE 18.67%
ROIC 12.56%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
A Yearly ROA, ROE, ROICA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of A (18.26%) is better than 87.72% of its industry peers.
  • A's Profit Margin has improved in the last couple of years.
  • A has a better Operating Margin (22.04%) than 91.23% of its industry peers.
  • A's Operating Margin has improved in the last couple of years.
  • The Gross Margin of A (52.60%) is better than 64.91% of its industry peers.
  • A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.04%
PM (TTM) 18.26%
GM 52.6%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
A Yearly Profit, Operating, Gross MarginsA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. A Health Analysis

2.1 Basic Checks

  • A has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for A has been reduced compared to 1 year ago.
  • Compared to 5 years ago, A has less shares outstanding
  • Compared to 1 year ago, A has an improved debt to assets ratio.
A Yearly Shares OutstandingA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
A Yearly Total Debt VS Total AssetsA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 4.64 indicates that A is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of A (4.64) is better than 84.21% of its industry peers.
  • The Debt to FCF ratio of A is 3.38, which is a good value as it means it would take A, 3.38 years of fcf income to pay off all of its debts.
  • A has a Debt to FCF ratio of 3.38. This is amongst the best in the industry. A outperforms 80.70% of its industry peers.
  • A Debt/Equity ratio of 0.49 indicates that A is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.49, A is in line with its industry, outperforming 40.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.38
Altman-Z 4.64
ROIC/WACC1.17
WACC10.72%
A Yearly LT Debt VS Equity VS FCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A has a Current Ratio of 2.07. This indicates that A is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.07, A is doing worse than 61.40% of the companies in the same industry.
  • A Quick Ratio of 1.59 indicates that A should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.59, A is doing worse than 61.40% of the companies in the same industry.
  • A does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.59
A Yearly Current Assets VS Current LiabilitesA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. A Growth Analysis

3.1 Past

  • A shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.03%.
  • The Earnings Per Share has been growing by 11.21% on average over the past years. This is quite good.
  • The Revenue has grown by 8.14% in the past year. This is quite good.
  • A shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.41% yearly.
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%

3.2 Future

  • Based on estimates for the next years, A will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.45% on average per year.
  • Based on estimates for the next years, A will show a quite strong growth in Revenue. The Revenue will grow by 8.09% on average per year.
EPS Next Y9.24%
EPS Next 2Y9.74%
EPS Next 3Y10.3%
EPS Next 5Y13.45%
Revenue Next Year6.82%
Revenue Next 2Y6.47%
Revenue Next 3Y6.54%
Revenue Next 5Y8.09%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
A Yearly Revenue VS EstimatesA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
A Yearly EPS VS EstimatesA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. A Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.07, the valuation of A can be described as rather expensive.
  • Based on the Price/Earnings ratio, A is valued cheaply inside the industry as 82.46% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, A is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 16.82, the valuation of A can be described as correct.
  • A's Price/Forward Earnings ratio is rather cheap when compared to the industry. A is cheaper than 84.21% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.99, A is valued a bit cheaper.
Industry RankSector Rank
PE 20.07
Fwd PE 16.82
A Price Earnings VS Forward Price EarningsA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 71.93% of the companies in the same industry are more expensive than A, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, A is valued a bit cheaper than 64.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.16
EV/EBITDA 18.34
A Per share dataA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of A may justify a higher PE ratio.
PEG (NY)2.17
PEG (5Y)1.79
EPS Next 2Y9.74%
EPS Next 3Y10.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. A Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.89%, A is not a good candidate for dividend investing.
  • A's Dividend Yield is rather good when compared to the industry average which is at 0.11. A pays more dividend than 98.25% of the companies in the same industry.
  • With a Dividend Yield of 0.89, A pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.89%

5.2 History

  • The dividend of A is nicely growing with an annual growth rate of 6.57%!
  • A has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.57%
Div Incr Years0
Div Non Decr Years0
A Yearly Dividends per shareA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • A pays out 21.94% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of A is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.94%
EPS Next 2Y9.74%
EPS Next 3Y10.3%
A Yearly Income VS Free CF VS DividendA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
A Dividend Payout.A Dividend Payout, showing the Payout Ratio.A Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

A Fundamentals: All Metrics, Ratios and Statistics

AGILENT TECHNOLOGIES INC

NYSE:A (4/29/2026, 10:48:02 AM)

113.005

-1.87 (-1.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength18.63
Industry Growth54.04
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners93.64%
Inst Owner Change-0.07%
Ins Owners0.13%
Ins Owner Change4.07%
Market Cap31.94B
Revenue(TTM)7.07B
Net Income(TTM)1.29B
Analysts80
Price Target164.58 (45.64%)
Short Float %1.59%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 0.89%
Yearly Dividend0.99
Dividend Growth(5Y)6.57%
DP21.94%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.09%
Min EPS beat(2)-2.58%
Max EPS beat(2)-1.6%
EPS beat(4)1
Avg EPS beat(4)-1.06%
Min EPS beat(4)-2.58%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.21%
EPS beat(12)8
Avg EPS beat(12)0.61%
EPS beat(16)11
Avg EPS beat(16)1.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.44%
Max Revenue beat(2)-0.43%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)2.3%
Revenue beat(8)2
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.34%
Revenue beat(16)7
Avg Revenue beat(16)0.07%
PT rev (1m)-4.12%
PT rev (3m)-3.59%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)0.92%
EPS NY rev (1m)0.25%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)1.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 20.07
Fwd PE 16.82
P/S 4.52
P/FCF 32.16
P/OCF 22.88
P/B 4.62
P/tB 15.98
EV/EBITDA 18.34
EPS(TTM)5.63
EY4.98%
EPS(NY)6.72
Fwd EY5.95%
FCF(TTM)3.51
FCFY3.11%
OCF(TTM)4.94
OCFY4.37%
SpS25
BVpS24.44
TBVpS7.07
PEG (NY)2.17
PEG (5Y)1.79
Graham Number55.6462 (-50.76%)
Profitability
Industry RankSector Rank
ROA 10.07%
ROE 18.67%
ROCE 14.72%
ROIC 12.56%
ROICexc 14.98%
ROICexgc 32.42%
OM 22.04%
PM (TTM) 18.26%
GM 52.6%
FCFM 14.06%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
ROICexc(3y)16.03%
ROICexc(5y)16.51%
ROICexgc(3y)38.11%
ROICexgc(5y)42.31%
ROCE(3y)15.36%
ROCE(5y)15.95%
ROICexgc growth 3Y-8.87%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y-4.92%
ROICexc growth 5Y7.55%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.38
Debt/EBITDA 1.82
Cap/Depr 142.4%
Cap/Sales 5.7%
Interest Coverage 15.73
Cash Conversion 75.87%
Profit Quality 76.98%
Current Ratio 2.07
Quick Ratio 1.59
Altman-Z 4.64
F-Score6
WACC10.72%
ROIC/WACC1.17
Cap/Depr(3y)132.79%
Cap/Depr(5y)109.81%
Cap/Sales(3y)5.34%
Cap/Sales(5y)4.65%
Profit Quality(3y)104.6%
Profit Quality(5y)100.47%
High Growth Momentum
Growth
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
EPS Next Y9.24%
EPS Next 2Y9.74%
EPS Next 3Y10.3%
EPS Next 5Y13.45%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%
Revenue Next Year6.82%
Revenue Next 2Y6.47%
Revenue Next 3Y6.54%
Revenue Next 5Y8.09%
EBIT growth 1Y0.19%
EBIT growth 3Y-1.19%
EBIT growth 5Y12.72%
EBIT Next Year26.25%
EBIT Next 3Y14.67%
EBIT Next 5Y11.62%
FCF growth 1Y-39.78%
FCF growth 3Y4.11%
FCF growth 5Y7.51%
OCF growth 1Y-28.81%
OCF growth 3Y5.92%
OCF growth 5Y11.1%

AGILENT TECHNOLOGIES INC / A Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 7 / 10 to A.


Can you provide the valuation status for AGILENT TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 5 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.


What is the profitability of A stock?

AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.


Can you provide the financial health for A stock?

The financial health rating of AGILENT TECHNOLOGIES INC (A) is 8 / 10.


Can you provide the expected EPS growth for A stock?

The Earnings per Share (EPS) of AGILENT TECHNOLOGIES INC (A) is expected to grow by 9.24% in the next year.